All News

AAO-HNS Continues Advocacy on Hypoglossal Nerve Stimulation Coverage for Treatment of Obstructive Sleep Apnea (7/20/20)

AAO-HNS Continues Advocacy on Hypoglossal Nerve Stimulation Coverage for Treatment of Obstructive Sleep Apnea (7/20/20)
AAO-HNS Continues Advocacy on Hypoglossal Nerve Stimulation Coverage for Treatment of Obstructive Sleep Apnea (7/20/20)

April 21, 2021

On July 20, the AAO-HNS sent comments to Anthem opposing their medical policy designating hypoglossal nerve stimulation (HGNS) as experimental / investigational for the treatment of obstructive sleep apnea. The Academy requested Anthem revisit and amend its policy given the strong evidence supporting HGNS as efficacious in improving outcomes in patients with OSA.

Related Content

AAO-HNS Opposition Leads to Positive Update on United Healthcare’s Rhinoplasty and Nasal Procedures Policy

Private Payer Advocacy

Following advocacy efforts by the AAO-HNS and the American Academy for Facial Plastic and Reconstructive Surgery (AAFPRS), on June…

AAO-HNS Comments on UHC Changes to Rhinoplasty and Other Nasal Surgeries Policy

Private Payer Advocacy

On January 27, the Academy sent comments to United Healthcare (UHC) regarding revisions made to the coverage criteria in…

AAO-HNS Advocates for Immediate Change to Horizon’s Modifier 25 Policy

Advocacy, Private Payer Advocacy

Effective August 1, 2022, Horizon Blue Cross Blue Shield will reimburse E/M services appended with Modifier 25 at 50% if a…

Save the Date for the AAO-HNSF 2024 Annual Meeting & OTO EXPOLearn More